Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_assertion description "[We examined the effects of the mycotoxin cerulenin (a covalent FAS inactivator), and the novel small compound C75 (a slow-binding FAS inhibitor) on estradiol (E2)- and tamoxifen (TAM)-stimulated ER-driven molecular responses in Ishikawa cells, an in vitro model of well-differentiated human endometrial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_assertion evidence source_evidence_literature NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_assertion SIO_000772 15094777 NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_assertion wasDerivedFrom befree-20140225 NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_assertion wasGeneratedBy ECO_0000203 NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP584476.RAq-RVoK_vN2Bl7L28AdP88KVeqANK9l8etj0OsVz82EI130_provenance.